The phosphoinositide 3-kinase (PI3K)/Akt/mTOR pathway is a key oncogenic driver, implicated in tumorigenesis, metastasis, and therapy resistance, particularly in hormone receptor-positive (HR+) and triple-negative breast cancer (TNBC) [10,11]. This evidence concerns the gene AKT1 and triple-negative breast carcinoma.